Universal First-Trimester Screening Biomarkers for Diagnosis of Preeclampsia and Placenta Accreta Spectrum

Angelika V. Timofeeva(National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation), Gennady Sukhikh(National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation)
Biomolecules
February 4, 2025
10.3390/biom15020228
Cited by 5

Related Papers

Diagnostic Role of Cell-Free miRNAs in Identifying Placenta Accreta Spectrum during First-Trimester Screening
|International Journal of Molecular Sciences|2024|10
Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors
|International Journal of Molecular Sciences|2023|8
Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules
|Life|2022|6
Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules of Progesterone Receptor-Negative Phenotype of Serous Ovarian Tumors
|Preprints.org|2023|4
Diagnostic Role of Cell-Free miRNAs in Identifying Placenta Accreta Spectrum during the First-Trimester Screening
|Preprints.org|2023|1